Agrinos is a fully integrated biological input supplier with proprietary technology, internal manufacturing and global distribution capabilities. The company’s high yield technology product platform works in conjunction with other nutritional crop inputs to increase crop yield, improve soil health and reduce the environmental footprint of traditional agricultural practices.
“In addition to our leading position in crop protection, we intend to expand our global participation in bio-nutritional inputs that contribute to improving soil health. The acquisition of Agrinos is a major step toward achieving that strategic objective,” said Eric Wintemute, chairman and CEO of American Vanguard. “The Agrinos portfolio will complement our Greenplants liquid nutrition products which have enjoyed successful growth in the Central American market. Additionally, these biostimulant products are tailored perfectly for use in our SIMPAS prescription application system.”
According to Wintemute, in independent field trials conducted over the last eight years, Agrinos technology has delivered yield increases on the order of five to 10 percent on row crop applications in corn, soybeans, wheat, rice and cotton, and 10 to 17 percent in many high-value crops such as almonds, peanuts, tomatoes, melons and grapes.
Agrinos’ intellectual property includes nearly 50 patents issued and nearly 100 pending worldwide. The company has two manufacturing facilities including a state-of-the-art microbial input manufacturing facility located in Oregon (U.S.) capable of customizing high-quality strains and a high throughput manufacturer of high quality biostimulants using naturally derived raw materials located in Mexico.
“In short, the Agrinos biological platform will enhance our overall ability to provide comprehensive crop protection and nutritional solutions to growers internationally,” concluded Wintemute.